NNNN
Anbio Biotechnology·NASDAQ
--
--(--)
--
--(--)
NNNN Filings
Filing Date
Form Description
Form Type
2026-01-26
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-26 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-30
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Financials
2025-12-30 · Financials
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-13
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-13 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-04-28
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Financials
2025-04-28 · Financials
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025-02-21
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-02-21 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-02-19
Form 424B4 - Prospectus [Rule 424(b)(4)]
2025-02-19 ·
Form 424B4 - Prospectus [Rule 424(b)(4)]
2025-02-19
Form EFFECT - Notice of Effectiveness
2025-02-19 ·
Form EFFECT - Notice of Effectiveness
2025-02-18
Form CERT - Certification by an exchange approving securities for listing
2025-02-18 ·
Form CERT - Certification by an exchange approving securities for listing
2025-02-14
Form CORRESP - Correspondence
SEC Inquiries
2025-02-14 · SEC Inquiries
Form CORRESP - Correspondence
2025-02-14
Form CORRESP - Correspondence
SEC Inquiries
2025-02-14 · SEC Inquiries
Form CORRESP - Correspondence
